“…Since isogenic embryonic stem cell lines, known as NT-ESCs, can be derived from nucleartransferred embryos, this technology offers great hope for regenerative medicine. 40 However, due to technical restraints and ethical concerns, it is very hard to obtain patient-specific NT-ESC lines, 41 and until lately, only one research group has successfully derived hESC lines. 42 In 2006, reprogramming of mouse somatic cells into pluripotent stem cells was achieved by ectopically expressing four ESC-enriched transcription factors, namely Oct4, Sox2, Klf4, and C-myc.…”